BNP's New York Equity Walk Out Continues

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

BNP's New York Equity Walk Out Continues

BNP Paribas has lost three more of its equity derivatives professionals, this time to CDC IXIS Capital Markets and Banc of America Securities. Jason Megson, v.p. in single stock trading, and Michael Nevin, v.p. in equity derivatives sales, have joined CDC and Raj Malhotra, v.p. in index trading, has joined BofA. All have taken similar positions, according to officials familiar with the situation. The firm had already lost Jim Xu, an equity derivatives trader, (DW, 5/19) Kent Oz, head of financial institutional sales, (DW, 5/3) and Vuk Bulajic, head of U.S. equity derivatives (DW, 4/29).

At CDC Megson and Nevin will report to Bulajic, head of equity derivatives sales and marketing. At BofA, Malhotra reports to Ben Wilkinson, managing director and head of equity derivatives trading at BofA. Wilkinson and Jeff Hershberger, spokesman in New York, were unable to comment by press time. Wilkinson recently joined BofA from AIG Financial Products (DW, 5/19). Bulajic declined comment.

All three reported to Francois Carnet, U.S. head of equity derivatives at BNP. Carnet referred calls to press officers, who confirmed the departures, but declined further comment.

Related articles

Gift this article